Low Progesterone Receptor Expression Is Associated with Distant Metastasia in Estrogen Receptor Positive/HER2 Negative and Lymph Node Negative Breast Cancer

被引：0
|
作者：
Mendoza, Pia
Sonmez, Ceyda
Neely, Cameron
Zhang, Chao
Liu, Yuan
Li, Xiaoxian
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
228
引用
收藏
页码：59A / 59A
页数：1
相关论文
共 50 条
  • [31] Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
    Hefti, Marco M.
    Hu, Rong
    Knoblauch, Nicholas W.
    Collins, Laura C.
    Haibe-Kains, Benjamin
    Tamimi, Rulla M.
    Beck, Andrew H.
    BREAST CANCER RESEARCH, 2013, 15 (04)
  • [32] Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
    Marco M Hefti
    Rong Hu
    Nicholas W Knoblauch
    Laura C Collins
    Benjamin Haibe-Kains
    Rulla M Tamimi
    Andrew H Beck
    Breast Cancer Research, 15
  • [33] Should estrogen receptor positive and progesterone receptor negative and HER-2 negative breast cancer patients be considered as a luminal B subtype?
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (05): : 2529 - 2529
  • [34] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Ke-Da Yu
    Yi-Zhou Jiang
    Shuang Hao
    Zhi-Ming Shao
    BMC Medicine, 13
  • [35] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Yu, Ke-Da
    Jiang, Yi-Zhou
    Hao, Shuang
    Shao, Zhi-Ming
    BMC MEDICINE, 2015, 13
  • [36] Ki-67 index value and progesterone receptor status predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor positive and HER2 negative tumors
    Arima, Nobuyuki
    Nishimura, Reiki
    Osako, Tomofumi
    Nishiyama, Yasuyuki
    Okumura, Yasuhiro
    Fujisue, Mamiko
    Toyozumi, Yasuo
    CANCER RESEARCH, 2018, 78 (04)
  • [37] Clinical considerations for estrogen receptor-negative/ progesterone receptor-positive/HER2-negative (ER-PR+HER2-) breast cancer
    Rala de Paula, Bruno Henrique
    Crocamo, Susanne
    Bines, Jose
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [38] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Garcia, Ximena
    Elia, Andres
    Galizzi, Lucrecia
    May, Maria
    Spengler, Eunice
    Martinez Vazquez, Paula
    Burruchaga, Javier
    Gass, Hugo
    Lanari, Claudia
    Lamb, Caroline A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (01) : 257 - 263
  • [39] Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Ximena García
    Andrés Elía
    Lucrecia Galizzi
    María May
    Eunice Spengler
    Paula Martínez Vázquez
    Javier Burruchaga
    Hugo Gass
    Claudia Lanari
    Caroline A. Lamb
    Breast Cancer Research and Treatment, 2020, 180 : 257 - 263
  • [40] Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice
    Rath, Sushmita
    Elamarthi, Prahalad
    Parab, Pallavi
    Gulia, Seema
    Nandhana, Ravindra
    Mokal, Smruti
    Kembhavi, Yogesh
    Perumal, Prema
    Bajpai, Jyoti
    Ghosh, Jaya
    Gupta, Sudeep
    PLOS ONE, 2021, 16 (07):
12345